APPLICATION
ANDA077774
TYPE
ANDA
ORIGINAL APPROVAL
2008-12-29
LATEST ACTION
2012-01-31
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued
Products
STAVUDINEDiscontinued
STAVUDINE 1MG/ML · FOR SOLUTION · ORAL
Approval history
2012-01-31Labeling · Supplement 6AP
2011-12-29Labeling · Supplement 5AP
2011-07-22Labeling · Supplement 4AP
2009-09-29Labeling · Supplement 2AP
2009-03-16Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.